Previous sinus or skull base surgery of an extensive nature is cause for re-evaluating whether to do nasopharyngeal swab testing to detect COVID-19, a new study that included authors from UT Health San Antonio indicates. Other testing, such as at the back of the throat, may be warranted instead.
COVID?19 has altered the labor market for millions of people, including public health graduates, yet an analysis of job postings for Master's level public health graduates showed that job postings remained at the same levels as before the pandemic, according to a new study at Columbia University Mailman School of Public Health.
Shark scientists at Georgia Aquarium, Scripps Institution of Oceanography at UC San Diego, and Dalhousie University are challenging the status quo in shark and ray mating research in a new study that looks at biological drivers of multiple paternity in these animals.
A systematic screening program designed for athletes testing positive for COVID-19 has detected a low incidence of inflammatory heart disease, so far returning professional athletes safely to sport.
Many species might be left vulnerable in the face of climate change, unable to adapt their physiologies to respond to rapid global warming. According to a team of international researchers, species evolve heat tolerance more slowly than cold tolerance, and the level of heat they can adapt to has limits.
Texas A&M University College of Medicine ressearchers have recently discovered that cytisine -- a smoking cessation drug commonly used in Europe -- reduces the loss of dopamine neurons in females. These findings provide potential evidence for the use of the drug to treat Parkinson's disease or stop its progression in women.
New research from Washington University School of Medicine in St. Louis has found that new variants of the virus that causes COVID-19 can evade antibodies that work against the original form of the virus that sparked the pandemic, potentially undermining the effectiveness of vaccines and antibody-based drugs now being used to prevent or treat COVID-19.
Researchers have developed a method based on artificial intelligence that rapidly identifies currently available medications that may treat Alzheimer's disease. The method also reveals potential new treatment targets for the disease.
A preclinical study from the laboratory of Dr. Huda Zoghbi, professor at Baylor College of Medicine and director of the Jan and Dan Duncan Neurological Research Institute at Texas Children's Hospital, provides experimental evidence that supports the use of antisense oligonucleotides as a feasible strategy to treat MDS. The study also offers crucial insights into the pharmacodynamics of this approach, which will serve as an important guide for the design and implementation of future clinical trials for this disorder.
This Viewpoint proposes ways to maximize vaccine efficacy and allocation given the rise of coronavirus variants and authorization of a Johnson & Johnson vaccine, including reserving the latter for younger healthier populations, boosting it with a single-dose messenger RNA (mRNA) vaccination and single mRNA immunization of people with prior documented SARS-CoV-2 infection.